Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CNP-PB Stock Summary
In the News
CNP-PB Financial details
Company Rating
Buy
Market Cap
0
Income
917M
Revenue
8.7B
Book val./share
15.31
Cash/share
1
Dividend
0.77
Dividend %
2.63%
Employees
9.54K
Optionable
No
Shortable
Yes
Earnings
-
P/E
-19.47
Forward P/E
-
PEG
14.16
P/S
1280951593.8
P/B
1.8
P/C
46.31
P/FCF
-30.7
Quick Ratio
0.47
Current Ratio
0.61
Debt / Equity
1.93
LT Debt / Equity
1.82
-
-
EPS (TTM)
1.38
EPS next Y
-
EPS next Q
-
EPS this Y
-14.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
0.44%
Revenue last 5Y
2.83%
Revenue Q/Q
17.31%
EPS Q/Q
-26.83%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-9%
ROC
0.04%
Gross Margin
39%
Oper. Margin
17%
Profit Margin
-10%
Payout
-68%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
46.54-47.05
52W High
-1.47%
52W Low
+0.67%
RSI
-
Rel Volume
5.87
Avg Volume
304.42K
Volume
1.79M
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
0.986013
-
-
Volatility
0%, 0%
Prev Close
0%
Price
46.31
Change
-0.49%
CNP-PB Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 15.07 | 13.97 | 14.09 | 14.81 | 13.78 | |
Net income per share | 1.58 | -1.11 | 1.13 | 1.68 | 1.45 | |
Operating cash flow per share | 3.26 | 3.76 | 0.04 | 2.88 | 6.14 | |
Free cash flow per share | -1.73 | -1.13 | -5.3 | -4.15 | -0.83 | |
Cash per share | 2.12 | 1.92 | 2.81 | 0.93 | 1 | |
Book value per share | 16.65 | 15.72 | 15.88 | 15.96 | 15.32 | |
Tangible book value per share | 6.29 | 6.78 | 8.56 | 9.08 | 8.73 | |
Share holders equity per share | 16.65 | 15.72 | 15.88 | 15.96 | 15.32 | |
Interest debt per share | 31.23 | 26.25 | 28.05 | 27.61 | 30.62 | |
Market cap | 13.69B | 11.49B | 16.55B | 18.88B | 18.03B | |
Enterprise value | 28.56B | 24.78B | 32.42B | 35.66B | 36.55B | |
P/E ratio | 17.31 | -19.44 | 24.77 | 17.86 | 19.66 | |
Price to sales ratio | 1.81 | 1.55 | 1.98 | 2.03 | 2.07 | |
POCF ratio | 8.36 | 5.76 | 752.22 | 10.43 | 4.65 | |
PFCF ratio | -15.77 | -19.12 | -5.27 | -7.24 | -34.4 | |
P/B Ratio | 1.64 | 1.38 | 1.76 | 1.88 | 1.86 | |
PTB ratio | 1.64 | 1.38 | 1.76 | 1.88 | 1.86 | |
EV to sales | 3.78 | 3.34 | 3.88 | 3.83 | 4.2 | |
Enterprise value over EBITDA | 10.73 | 23.58 | 11.85 | 12.61 | 11.43 | |
EV to operating cash flow | 17.44 | 12.42 | 1.47K | 19.7 | 9.43 | |
EV to free cash flow | -32.91 | -41.24 | -10.32 | -13.67 | -69.76 | |
Earnings yield | 0.06 | -0.05 | 0.04 | 0.06 | 0.05 | |
Free cash flow yield | -0.06 | -0.05 | -0.19 | -0.14 | -0.03 | |
Debt to equity | 1.81 | 1.61 | 1.71 | 1.68 | 1.93 | |
Debt to assets | 0.43 | 0.4 | 0.43 | 0.44 | 0.47 | |
Net debt to EBITDA | 5.59 | 12.65 | 5.8 | 5.93 | 5.79 | |
Current ratio | 0.99 | 0.61 | 1.72 | 0.92 | 0.78 | |
Interest coverage | 1.89 | -0.34 | 2.58 | 2.99 | 2.51 | |
Income quality | 2.07 | -2.58 | 0.01 | 1.71 | 4.23 | |
Dividend Yield | 0.05 | 0.05 | 0.03 | 0.03 | 0.03 | |
Payout ratio | 0.88 | -0.9 | 0.74 | 0.46 | 0.58 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.14 | 0.14 | 0.11 | 0.11 | 0.1 | |
Capex to operating cash flow | -1.53 | -1.3 | -143.82 | -2.44 | -1.14 | |
Capex to revenue | -0.33 | -0.35 | -0.38 | -0.47 | -0.51 | |
Capex to depreciation | -1.91 | -2.13 | -2.4 | -3.43 | -3.14 | |
Stock based compensation to revenue | 0.01 | 0.26 | -0.01 | 0.01 | 0 | |
Graham number | 24.29 | 19.84 | 20.06 | 24.56 | 22.38 | |
ROIC | 0.04 | -0.01 | 0.05 | 0.04 | 0.05 | |
Return on tangible assets | 0.03 | -0.02 | 0.02 | 0.03 | 0.03 | |
Graham Net | -49.62 | -43.14 | -42.82 | -41.66 | -44.44 | |
Working capital | -41M | -1.91B | 3.07B | -414M | -837M | |
Tangible asset value | 3.48B | 3.65B | 5.12B | 5.71B | 5.51B | |
Net current asset value | -23.23B | -22.2B | -20.91B | -23.8B | -27.02B | |
Invested capital | 1.81 | 1.61 | 1.71 | 1.68 | 1.93 | |
Average receivables | 1.42B | 1.27B | 1.23B | 1.44B | 1.5B | |
Average payables | 1.06B | 868.5M | 1.02B | 1.27B | 1.13B | |
Average inventory | 433M | 486M | 554M | 742M | 823M | |
Days sales outstanding | 61.62 | 62.15 | 52.62 | 65.51 | 55.4 | |
Days payables outstanding | 67.3 | 69.36 | 84.85 | 83.3 | 66.81 | |
Days of inventory on hand | 35.94 | 40.65 | 43.13 | 53.97 | 56.1 | |
Receivables turnover | 5.92 | 5.87 | 6.94 | 5.57 | 6.59 | |
Payables turnover | 5.42 | 5.26 | 4.3 | 4.38 | 5.46 | |
Inventory turnover | 10.16 | 8.98 | 8.46 | 6.76 | 6.51 | |
ROE | 0.09 | -0.07 | 0.07 | 0.11 | 0.09 | |
Capex per share | -4.99 | -4.89 | -5.34 | -7.02 | -6.98 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.31 | 4.41 | 2.97 | 2.95 | 3.46 | |
Net income per share | 0.21 | 0.52 | 0.19 | 0.45 | 0.3 | |
Operating cash flow per share | 0.77 | 2.72 | 1.22 | 0.93 | 1.28 | |
Free cash flow per share | -1.36 | 0.94 | -0.58 | -0.76 | -0.43 | |
Cash per share | 0.93 | 1.05 | 1.16 | 1.09 | 1 | |
Book value per share | 15.96 | 16.43 | 16.43 | 15.19 | 15.31 | |
Tangible book value per share | 9.07 | 9.56 | 9.83 | 8.59 | 8.72 | |
Share holders equity per share | 15.96 | 16.43 | 16.43 | 15.19 | 15.31 | |
Interest debt per share | 26.99 | 26.42 | 27.15 | 29.24 | 29.81 | |
Market cap | 18.88B | 18.57B | 18.4B | 16.95B | 18.03B | |
Enterprise value | 35.66B | 34.96B | 35.15B | 35.1B | 36.56B | |
P/E ratio | 35.22 | 14.28 | 38.97 | 15.02 | 23.48 | |
Price to sales ratio | 6.96 | 6.68 | 9.81 | 9.11 | 8.26 | |
POCF ratio | 38.93 | 10.84 | 23.92 | 28.87 | 22.32 | |
PFCF ratio | -22.08 | 31.47 | -50.12 | -35.53 | -66.79 | |
P/B Ratio | 1.88 | 1.79 | 1.77 | 1.77 | 1.87 | |
PTB ratio | 1.88 | 1.79 | 1.77 | 1.77 | 1.87 | |
EV to sales | 13.15 | 12.58 | 18.75 | 18.87 | 16.76 | |
Enterprise value over EBITDA | 57.8 | 40.04 | 47.37 | 38.78 | 53.93 | |
EV to operating cash flow | 73.53 | 20.41 | 45.71 | 59.79 | 45.25 | |
EV to free cash flow | -41.71 | 59.25 | -95.77 | -73.58 | -135.42 | |
Earnings yield | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | -0.05 | 0.03 | -0.02 | -0.03 | -0.01 | |
Debt to equity | 1.68 | 1.59 | 1.64 | 1.91 | 1.93 | |
Debt to assets | 0.44 | 0.44 | 0.45 | 0.47 | 0.47 | |
Net debt to EBITDA | 27.2 | 18.77 | 22.58 | 20.06 | 27.33 | |
Current ratio | 0.92 | 1 | 0.88 | 0.78 | 0.78 | |
Interest coverage | 2.57 | 3.61 | 2.28 | 2.83 | 1.6 | |
Income quality | 3.62 | 5.27 | 6.52 | 2.08 | 4.21 | |
Dividend Yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Payout ratio | 0.84 | 0.44 | 1.02 | 0.51 | 0.66 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.11 | 0.11 | 0.11 | 0.11 | 0.1 | |
Capex to operating cash flow | -2.76 | -0.66 | -1.48 | -1.81 | -1.33 | |
Capex to revenue | -0.49 | -0.4 | -0.61 | -0.57 | -0.49 | |
Capex to depreciation | -4.27 | -3.52 | -3.26 | -2.84 | -3 | |
Stock based compensation to revenue | 0.02 | 0 | 0 | 0 | 0 | |
Graham number | 8.74 | 13.81 | 8.31 | 12.36 | 10.24 | |
ROIC | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | |
Return on tangible assets | 0 | 0.01 | 0 | 0.01 | 0.01 | |
Graham Net | -41.66 | -40.27 | -41.08 | -43.48 | -44.42 | |
Working capital | -414M | -11M | -382M | -871M | -837M | |
Tangible asset value | 5.71B | 6.06B | 6.21B | 5.43B | 5.51B | |
Net current asset value | -23.8B | -24.26B | -24.93B | -26.39B | -27.02B | |
Invested capital | 1.68 | 1.59 | 1.64 | 1.91 | 1.93 | |
Average receivables | 1.38B | 1.48B | 1.11B | 1.06B | 1.25B | |
Average payables | 1.19B | 1.14B | 883M | 797.5M | 840M | |
Average inventory | 879M | 828.5M | 755M | 769.5M | 790M | |
Days sales outstanding | 55.54 | 41.42 | 45.36 | 56.81 | 54.45 | |
Days payables outstanding | 64.01 | 47.2 | 73.7 | 81.65 | 60.15 | |
Days of inventory on hand | 41.47 | 39.47 | 64.58 | 86.68 | 50.51 | |
Receivables turnover | 1.62 | 2.17 | 1.98 | 1.58 | 1.65 | |
Payables turnover | 1.41 | 1.91 | 1.22 | 1.1 | 1.5 | |
Inventory turnover | 2.17 | 2.28 | 1.39 | 1.04 | 1.78 | |
ROE | 0.01 | 0.03 | 0.01 | 0.03 | 0.02 | |
Capex per share | -2.13 | -1.78 | -1.8 | -1.69 | -1.71 |
CNP-PB Frequently Asked Questions
What is CenterPoint Energy, Inc. stock symbol ?
CenterPoint Energy, Inc. is a US stock , located in Houston of Tx and trading under the symbol CNP-PB
What is CenterPoint Energy, Inc. stock quote today ?
CenterPoint Energy, Inc. stock price is $46.31 today.
Is CenterPoint Energy, Inc. stock public?
Yes, CenterPoint Energy, Inc. is a publicly traded company.